Alpha Cognition is trading 5.32% lower at $8.19, with no clear company-specific announcement explaining the decline. - The October 13 patent-application news concerned manufacturing technology for ZUNVEYL and does not directly explain the move. - October 15 market coverage reported wholesale prices surged; core PPI rose 0.7% versus 0.3% expected, sending stocks down early. - Biotech was higher, so a sector-wide explanation is unsupported; inflation-related macro sentiment is the likeliest context, not a confirmed direct cause.